Occurrence of elevated protoporphyrin levels in relation to lead burden in infants

Area of Science:

• Pediatric toxicology
• Environmental health
• Hematology

Background:

• Infant exposure to environmental toxins is a significant public health concern.
• Blood lead (PbB) levels are a key indicator of lead exposure in children.
• Erythrocyte protoporphyrin (EP) is a sensitive biomarker for disruptions in heme synthesis, often linked to lead exposure and iron deficiency.

Purpose of the Study:

• To investigate the relationship between blood lead levels (PbB) and erythrocyte protoporphyrin (EP) in infants aged 6 to 24 months.
• To determine the threshold of PbB at which EP levels become significantly elevated.
• To assess the influence of anemia on the PbB-EP relationship.

Main Methods:

• Semiannual measurements of PbB, EP, and hematocrit were conducted in 232 infants.
• Infants ranged from 6 to 24 months of age.
• Statistical analysis was performed to evaluate the association between PbB and EP, controlling for hematocrit levels.

Main Results:

• The average PbB level was 7 (SD = 5) micrograms/dl, with a range of 0 to 64 micrograms/dl.
• Elevated EP incidence was not associated with PbB levels below 15 micrograms/dl.
• Infants with PbB above 15 micrograms/dl showed a fourfold greater incidence of elevated EP, a finding that persisted after excluding anemic samples.

Conclusions:

• Blood lead levels exceeding 15 micrograms/dl are strongly associated with deranged heme synthesis in infants.
• Erythrocyte protoporphyrin serves as a reliable indicator of lead-induced heme synthesis impairment at elevated PbB levels.
• The study underscores the importance of monitoring lead exposure in infants and highlights potential confounding factors like iron deficiency.